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Abstract
Platelet activity and platelet-endothelial cell interactions are important in the acute development of thrombosis, as well as in
the pathogenesis of cardiovascular disease. An increasing number of foods have been reported to have platelet-inhibitory
actions, and research with a number of ﬂavanol-rich foods, including, grape juice, cocoa and chocolate, suggests that these
foods may provide some protection against thrombosis. In the present report, we review a series of invivo studies on the effects
of ﬂavanol-rich cocoa and chocolate on platelet activation and platelet-dependent primary hemostasis. Consumption of
ﬂavanol-rich cocoa inhibited severalmeasures of platelet activity including, epinephrine- andADP-induced glycoprotein (GP)
IIb/IIIa and P-Selectin expression, platelet microparticle formation, and epinephrine-collagen and ADP-collagen induced
primary hemostasis. The epinephrine-induced inhibitory effects on GP IIb/IIIa and primary hemostasis were similar to,
though less robust than those associated with the use of low dose (81mg) aspirin. These data, coupled with information from
other studies, support the concept that ﬂavanols present in cocoa and chocolate can modulate platelet function through a
multitude of pathways.
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Introduction
Platelet activity and platelet-endothelial cell inter-
actionsareimportantnotonlyintheacutedevelopment
of thrombosis, but also in the pathogenesis of
cardiovascular disease (CVD) (Osterud 1997, Rauch
etal.2001,Ruggeri,2002).Frequently,theﬁrstclinical
manifestation,andoften-fatalevent,ofCVDisthrombi
release from unstable atherosclerotic plaque, resulting
in myocardial ischemia/infarction or stroke. Thus,
antiplatelet therapies such as, aspirin (ASA), clopido-
grel and glycoprotein IIb/IIIa inhibitors, are important
components of therapeutic regimes for conditions
associated with vascular pathology (Schafer 1996,
Hennekens 1997, Bhatt and Topol 2000, Rauch et al.
2001). However, most of these therapies are employed
to prevent secondary, rather than primary thrombotic
events. Interestingly, an increasing number of foods
and beverages (e.g. ﬁsh rich in omega-3 fatty acids,
onions, tea, grape juice and garlic) have been observed
to have platelet-inhibitory actions (Srivastava 1986,
Apitz-Castro et al. 1992, Schafer 1996); and research
with a number of ﬂavanol-rich foods and beverages,
such as grape juice, tea, cocoa and chocolate, suggests
that these foods be particularly beneﬁcial with respect
to platelet function (Demrow et al. 1995, Pace-Asciak
et al. 1996, Osman et al. 1998, Keevil et al. 2000,
Freedman et al. 2001, Kris-Etherton and Keen 2002).
Historically, the formulation of dietary guidelines
has been based, in part, by describing diets that will
provide adequate amounts of vitamins, minerals,
essential fatty acids and ﬁber that will maintain health.
In programs of chronic disease prevention, such as
CVD, diet is considered an integral component,
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achieve desirable levels of blood lipids, and pressure
(Krauss et al. 2000, Hu and Willett 2002). In addition
to the maintenance of a healthy body weight, current
American Heart Association recommendations
include the daily consumption of a variety of fruits
andvegetablesandgrainproducts(Kraussetal.2000).
Such foods contain vitamins, minerals and macro-
nutrients that are known to provide certain health
beneﬁts, however, there is an increasing recognition of
the fact that some foods, including fruits and
vegetables, provide a greater, or different, health
beneﬁts than others. In an effort to better understand
the different health properties of foods increasing
attention has been given to the characterization of a
wide number of plant polyphenolic compounds,
including those in the ﬂavonoid class. It is now
recognized that ﬂavonoids can affect a variety of
enzymatic, and inter- and intracellular systems which
can modulate immune function, inﬂammatory pro-
cesses, vascular reactivity, antioxidant mechanisms,
cellproliferationandplateletfunction(Middletonetal.
2000), thus, making these nutrients important com-
ponents of the nutritional proﬁle of the diet.
The ﬂavonoids are the largest and most widely
distributed class of phytochemicals, and can be found
in foods such as red wine, tea, grapes, cocoa and
chocolate (Kris-Etherton and Keen 2002). Certain
cocoas and chocolate are unusual in that they can
contain very high amounts of the ﬂavanol monomers
epicatechin and catechin, and their oligomers known
as procyanidins (Hammerstone et al. 1999). In this
paper, we review some of the effects of ﬂavanols found
in cocoa and chocolate on platelet function, and their
potential as cardioprotective dietary agents.
Potential cocoa components, exclusive of ﬂavonoids, that
inﬂuence platelet reactivity
Prior to an in depth discussion of the potential effects
that cocoa ﬂavonoids can have of platelet function, it is
important to note that several other components in
chocolate can potentially affect platelet function and
cardiovascular health. In addition to the ﬂavonoids,
foods derived from cocoa are rich in minerals, lipid,
and other non-ﬂavonoid-based phytochemicals
(Chevaux et al. 2001, Rios et al. 2003, Steinberg
et al. 2003). Several minerals that are found in large
amounts in cocoa may potentially provide some
protection against platelet activation and thrombus
formation. When measured on a per serving basis,
dark and milk chocolate (44g/serving) contain an
equal or greater amounts of potassium, magnesium
and calcium than do apples, red wine and cranberry
juice (Steinberg et al. 2003). High potassium intakes
have been associated with a reduced risk for CVD
(Young et al. 1995), currently 3500mg/day is recom-
mended for primary prevention of hypertension
(Whelton et al. 2002). In addition, potassium has
been reported to decrease lesion formation after
balloon angioplasty in rat and swine models, and
reduce thrombosis formation in dogs as measured by
the Folts model of coronary artery thrombosis
(Lin and Young 1994, Ma et al. 2000, 2001). The
magnesium concentration in chocolate and cocoa can
be substantial being sufﬁcient to correct chronic
magnesium deﬁciencies in certain animal models
(Planells et al. 1997). With regards to platelet
function, Hughes and Tonks (Hughes and Tonks
1966) ﬁrst observed that magnesium reduced ADP-
induced platelet aggregation. In addition, magnesium
has been reported to decrease collagen-induced
platelet activation, possibly through changes in
membrane ﬂuidity and reduced thromboxane forma-
tion (Sheu et al. 2002). Platelet activation and
aggregation is accompanied with increases in intra-
cellular calcium, leading to activation of several
different platelet secondary messenger and enzyme
systems. Thus, a high dietary intake of calcium could
potentially affect numerous platelet systems. Attenu-
ation in platelet aggregation was observed in
spontaneously hypertensive rats after calcium sup-
plementation (Otsuka et al. 1997), while in human
subjects calcium supplementation decreased intra-
platelet free calcium (Petrov and Lijnen, 1999).
Due to the high cocoa butter content of cocoa and
chocolate, these foods are sometimes viewed as “bad
foods” with regard to vascular health. However, while
60% of the fat in cocoa butter exists as saturated
stearic and palmitic acid (Otton et al. 1998, Steinberg
et al. 2003), studies to date have typically shown
neutral, or positive effects of cocoa consumption on
plasma lipid markers (Kris-Etherton and Mustad
1994, Saamman et al. 2000, Wan et al. 2001).Arecent
meta-analysis of 60 studies concluded that palmitic
acid had little effect on the ratio of total to HDL
cholesterol, while stearic acid tended to reduce this
ratio (Mensink et al. 2003). However, mixed results
have been reported when studies examined the effects
of individual fatty acids on platelet function, with
particular regards to stearic acid. Initial studies
reported a thrombogenic effect of stearic acid when
it was injected directly into animal models; although
this effect was muted when the stearic acid was mixed
with albumin (Hook 1994). A correlation was found
between stearic acid intake and coagulation protein
factor VII in subjects given diets high in saturated or
unsaturated fat, or a high carbohydrate diet (Mitro-
poulos et al. 1994). However, factor VII activation was
decreased in subjects given diets rich in stearic acid
compared to subjects given diets rich in palmitic acid
(Tholstrup et al. 1994). The eicosanoids, prostacyclin
and thromboxane, are potent platelet modulators
formed by cyclooxygenase from arachidonic acid.
While prostacyclin helps maintain the platelets in an
acquiescent state, thromboxane potentiates platelet
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concentration was observed in platelet phospholipids
after subjects consumed cocoa butter or chocolate as a
stearic acid source (Mustad et al. 1993), urinary
thromboxane and prostacyclin levels remain
unchanged following the consumption of diets rich
in stearic acid (Mustad et al. 1993, Blair et al. 1994).
Flavonoids
Cocoa and chocolate can be particularly rich in
ﬂavonoids, speciﬁcally the ﬂavonoid subclass ﬂavan-3-
ol (ﬂavanol) and oligomers of the ﬂavanols epicatechin
and catechin known as the proanthocyanidins
(procyanidins). Procyanidins with as many as 10
ﬂavanol subunits have been identiﬁed in cocoa and
chocolate. Studies with subjects given ﬂavanol- and
procyanidin-rich foods have reported positive vascular
effects including increased plasma antioxidant status
(Cao et al. 1998, Seraﬁni et al. 1998, Leenan et al.
2000, Wang et al. 2000, Wan et al. 2001), improved
endothelium function (Stein et al. 1999, Duffy et al.
2001), and reduced platelet reactivity (Keevil et al.
2000, Rein et al. 2000a,b,, Freedman et al. 2001, Holt
et al. 2002, Pearson et al. 2002). It is important to
note that the amount of ﬂavonoids and ﬂavanols in
cocoa and chocolate can vary widely as a result of a
multitude of factors. Agronomic factors and genetics
determine the ﬂavonoid content of plants prior to
harvest. After harvest, fermentation and other
processes, including roasting and alkalization, can
reduce the ﬁnal ﬂavonoid content of the product.
Thus, depending on harvesting and processing about
10% of the ﬂavonoids are preserved in the ﬁnal cocoa
and chocolate products (Kim and Keeney 1984,
Porter et al. 1991, Hannum and Erdman 2000, Keen
et al. 2002).
Platelet reactivity after cocoa consumption
In a series of experiments, cocoa was given to healthy
adult volunteers. Prior to the experiment, subjects
were instructed to abstain from ASA, and other non-
steroidal anti-inﬂammatory medications for at least
4–6 days, from alcoholic beverages for at least 2 days,
and from caffeine- or theobromine-containing foods
and ﬂavonoid-rich foods for at least 24h prior to and
during the test days. On the day of the experiment, all
volunteers were given ﬂavonoid-rich cocoa that
provided 897mg of total cocoa procyanidins as
determined by Adamson et al. (1999). Venous blood
was drawn prior to consumption of the ﬂavonoid-rich
cocoa 2 and 6h post consumption. Whole blood was
activated, ex vivo, with known platelet agonists
epinephrine (20mmol/l), or adenosine diphosphate
(ADP; 20mmol/l), or no stimulation, and in the
presence of ﬂuorescent-labeled antibodies to the
platelet surface proteins P-Selectin and the activated
conformation of glycoprotein (GP) IIb/IIIa. The level
of surface protein expression was detected using ﬂow
cytometry and the labeled platelets (Rein et al.
2000a,b, Pearson et al. 2002). Platelet-related
primary hemostasis was also determined in whole
blood by using a platelet function analyzer (PFA-
100e) (Rein et al. 2000a, Pearson et al. 2002). In
additional experiments, the effects of ﬂavonoid-rich
cocoa consumption on platelet activation and function
were compared to the consumption of dealcholized
red wine (DRW), a caffeine-containing beverage, and
to the known platelet inhibitor aspirin (ASA) (Rein
et al. 2000b, Pearson et al. 2002).
Upon activation by agonists such as collagen,
thrombin, ADP or epinephrine, platelets undergo a
series of intracellular signaling steps that convert the
GP IIb/IIIa receptor from a resting state on the
platelet surface to an active conformation that binds
ﬁbrinogen and von Willebrand factor (vWF), leading
to platelet aggregation (Topol et al. 1999). Antagon-
ists of ligand binding to the GP IIb/IIIa receptor have
been effectively used in patients undergoing percu-
taneous coronary interventions to minimize further
ischemic episodes (Topol et al. 1999, Bhatt and
Topol 2003). An extract of green tea ﬂavanols
(catechin, epicatechin, epigallocatechin, gallocate-
chin, gallocatechin gallate and epicatechin gallate)
reduced collagen-, ADP- and thrombin-induced
platelet aggregation, and GP IIb/IIIa expression in
ADP-stimulated platelets, in vitro (Kang et al. 2001).
We, therefore, examined the effect of ﬂavonoid-rich
cocoa consumption on the activated conformation of
GP IIb/IIIa. A decrease in epinephrine-stimulated
GP IIb/IIIa expression was observed 2 (Rein et al.
2000a,b, Pearson et al. 2002) and 6h (Rein et al.
2000a,b) after subjects consumed the cocoa. A similar
effect was also observed with ADP stimulation
(Rein et al. 2000a,b). In subjects given DRW, water
or a caffeine containing drink, no signiﬁcant changes
in either epinephrine (20mmol/l) or ADP (20mmol/l)
stimulation of GP IIb/IIIa were observed. When a
higher concentration of agonist was used (100mmol/l
ADP), a signiﬁcant increase in GP IIb/IIIa expression
was produced after DRW consumption (Table I).
P-Selectin, which is expressed on the surface of
activated platelets after degranulation, acts to mediate
platelet and leukocyte adherence, and has been
examined as a potential marker for assessment of
CVD risk (Parker et al. 2001, Romuk et al. 2002). In
subjects given cocoa, P-Selectin was reduced using
either ADP (Rein et al. 2000b) or epinephrine (Rein
et al. 2000a) stimulation 2 and 6h after ﬂavonoid-rich
cocoa consumption. No effect on platelet ADP or
epinephrine P-Selectin expression was observed when
subjects were given DRW or water (Rein et al.
2000a,b), however, an increase in epinephrine
stimulated platelet reactivity was observed when
subjects were given a caffeine-rich drink. These results
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who also observed reduced P-Selectin expression after
subjectswere given 234mg/dayof extracted ﬂavonoids
from cocoa in tablet form for 28 days. In addition,
Hodgson et al. (2001) reported reductions in soluble
P-Selectin levels in the plasma after subjects were
given 5 cups of black tea/day for 4 weeks.
Microparticles are membrane vesicles that are
shed from platelets upon activation, and exhibit
procoagulant activity (Horstman and Ahn 1999). A
signiﬁcant increase in platelet microparticles that
was also correlated to P-Selectin expression was
recently reported in patients with severe hyperten-
sion (Preston et al. 2003). In a healthy population of
subjects, consumption of ﬂavonoid-rich cocoa
reduced the amount of microparticles formed 2
and 6h post consumption (Rein et al. 2000a),
conversely, subjects given water and water with
caffeine showed increased microparticle formation
(Figure 1).
The PFA-100e measures platelet-related primary
hemostasis as the time it takes for ADP or
epinephrine stimulated whole blood to occlude an
aperture in a collagen membrane under simulated
small vessel shear conditions (Kundu et al. 1996,
Fressinaud et al. 1998). In the cocoa feeding studies,
an increase in the PFA-100e closure time in seconds
indicated a reduced propensity of platelets to adhere
and aggregate. Cocoa consumption increased
epinephrine-collagen closure times 6h after subjects
were given cocoa (Rein et al. 2000, Pearson et al.
2002). In addition, cocoa consumption increased
ADP-collagen stimulated closure times 2h post
consumption (Pearson et al. 2002). The caffeine-
containing beverage also prolonged ADP-collagen
stimulated closure times 6h post consumption (Rein
et al. 2000). It is important to note that it has been
recently reported that different platelet function
assays have varying sensitivities depending on the
drug regime (Hezard et al. 2003), thus it is important
to assess the effects of ﬂavonoids on platelet function
using a variety of assays. While black tea consump-
tion has shown either no (Duffy et al. 2001, Hodgson
et al. 2001) or a positive effect (Wolfram et al. 2002)
on platelet function using platelet rich plasma (PRP)
and aggregometry, cocoa ﬂavonoid consumption has
been shown to reduce platelet function using both
whole-blood aggregometry (Murphy et al. 2003) and
the PFA-100e (Rein et al. 2000a, Holt et al. 2002,
Pearson et al. 2002). Likewise, grape products, such
as grape juice, grape skin and seed extracts, and red
wine, have all been shown to reduce platelet reactivity
by using whole blood aggregometry (Osman et al.
1998, Keevil et al. 2000, Freedman et al. 2001,
Shanmuganayagam et al. 2002) or by cyclic ﬂow
reduction (Demrow et al. 1995).
Table I. The effects of DRW and cocoa procyanidins on in vivo
platelet activation in whole blood.
Glycoprotein IIb/IIIa expression
Unstimulated
Epinephrine
(2mM)
ADP
(2mM)
ADP
(100mM)
Water – – – –
Cocoa # 2 and 6h
ðp ¼ 0:035Þ
# 2 and 6h
ðp ¼ 0:008Þ
# 2 and 6h
ðp ¼ 0:001Þ
–
ðp ¼ 0:067Þ
DRW – – – " 2 and 6h
ðp ¼ 0:033Þ
Caffeine – " 2 and 6h
ðp ¼ 0:048Þ
–
ðp ¼ 0:066Þ
–
Table represents signiﬁcant trends in glycoprotein IIb/IIIa
expression in epinephrine-stimulated (20mmol/l) whole blood
after healthy human subjects were provided 300ml of the test
foods. Dashes represent no observed effect; otherwise p value is
reported (Friedman’s repeated-measures ANOVA on ranks and
Tukey’s all-pairwise multiple-comparison test) (Rein et al., 2000).
Figure 1. Platelet microparticle formation in response to the consumption of cocoa, water, or a caffeine beverage. Blood was drawn before
(0h) and 2 and 6h after the consumption of the indicated beverages. Data are presented as the percentage of platelet microparticles of total
CD42-positive events (mean ^ SEM). *Signiﬁcantly different from baseline (0h) with each treatment (Friedman’s repeated-measures
ANOVA on ranks and Tukey’s all-pairwise multiple-comparison test) (Rein et al. 2000a).
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oxygenase-1 (COX-1) through selective acetylation
of one of its serine residues (Patrono 1994). Platelets
lack the ability to regenerate this enzyme, thus
resulting in the irreversible loss of the potent
aggregator, thromboxane, for the lifespan of the
platelet (8–10 days). When the effects of cocoa were
compared to ASA use (Pearson et al. 2002), GP
IIb/IIIa expression on ADP-activated platelets was
reduced 6h after cocoa and ASA were taken
together, but not when either cocoa or ASA were
given to subjects separately. ASA was able to reduce
the surface expression of GPIIb/IIIa on epinephrine-
activated platelets 6h post consumption, while cocoa
reduced expression 2h post consumption. However,
when given together, ASA and cocoa consumption
was able to decrease the expression of GP IIb/IIIa
both 2 and 6h post consumption after epinephrine
stimulation (Figure 2). Similar results were observed
with P-Selectin expression. When given separately,
only ASA was able to reduce P-Selectin expression
(6h), however, when given together, both cocoa and
ASA were able to reduce P-selectin expression 2 and
6h after administration (Pearson et al. 2002).
With regards to platelet-related primary hemostasis,
cocoa increased PFA closure-times 2h post consump-
tion. As predicted, ASA had no effect on ADP-
collagen stimulation, however, when taken together
both cocoa and ASA signiﬁcantly increased closure
times 2 and 6h after administration. ASA signiﬁcantly
increased epinephrine-collagen PFA closure time 2
and 6h post consumption, while cocoa only increased
closure time 2h post consumption. Similar to ADP-
collagen stimulation, when ASA and cocoa were given
together, epinephrine-collagen PFA closure times
were signiﬁcantly increased from baseline both 2 and
6h post consumption (Figure 3) (Pearson et al. 2002).
In the above study, a rather large procyanidin
(800mg) dose was given to the subjects. In order to
determine the amount of procyanidin necessary to
produce the observed platelet effects subjects were
given a smaller ﬂavanol load (200mg) in the form of
25g of semi-sweet chocolate chips. ADP-collagen
and epinephrine-collagen stimulation prolonged
closure times 2h post-consumption, while 6h
post consumption, only ADP-collagen stimulation
prolonged closure times (Holt et al. 2002).
Potential mechanism regarding the effects of
ﬂavonoids on platelet reactivity
The ability of ﬂavanol-rich cocoa to favorably
modulate platelet reactivity was consistently demon-
strated. By several measures, ADP- and epinephrine-
induced GP IIb/IIIa and P-Selectin expression,
ADP- and epinephrine-collagen induced primary
hemostasis, and microparticle formation, ﬂavanol-
rich cocoa inhibited platelet reactivity. For the most
part, these effects were not seen with a caffeine-
containing beverage, suggesting that the caffeine
component of cocoa was not responsible for the
observed effects of the cocoa beverage. Furthermore,
the inhibitory effects of ﬂavanol-rich cocoa on
epinephrine-induced GP IIb/IIIa expression and
primary hemostasis were less profound, but similar
to those seen with low dose ASA.
Recently, intraperitoneal injections of catechin were
reported to inhibit radical-induced platelet hyper-
activity (Blaiche et al. 2002). Although cocoa contains
catechin, it is still unclear the speciﬁc or combination
of cocoa components that are responsible for the
observed ex vivo platelet-inhibitory effects. Another
recent study observed a greater platelet inhibitory
effect when grape seed and grape skin extracts were
Figure 2. Platelet activation in response to the consumption of cocoa, aspirin (ASA; 81mg) or ASA þ cocoa: Blood was drawn before (0h)
and 2 and 6h after the consumption of the test compounds. The percentage of platelets expressing activated GP IIb/IIIa (% PAC-1 antibody
binding) in whole blood after stimulation with 20mmol/l epinephrine; n ¼ 16 in each group. Data are presented as mean ^ SEM:
*Signiﬁcantly different from baseline (0h) with each treatment, p # 0:05 (Friedman’s repeated-measures ANOVA on ranks and Tukey’s all-
pairwise multiple-comparison test) (Pearson et al. 2002).
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separately (Shanmuganayagam et al. 2002). The
cocoa procyanidins, trimer and pentamer (3mmol/l),
have been shown to inhibit epinephrine-stimulated
GP IIb/IIIa, in vitro (Rein et al. 2000), and is
consistent with the observation that cocoa consump-
tion inhibits epinephrine-induced GP IIb/IIIa
expression. Although these data suggest that the
cocoa trimer and pentamer procyanidins are possible
platelet-inhibitory components, their comparison to in
vivo observations must be tempered by the fact that
only ﬂavanols and dimeric procyandins have been
detected in the circulation and the urine (Piskula and
Terao 1998, Donovan et al. 1999, Richelle et al. 1999,
Baba et al. 2000, Holt et al. 2002), and mostly
as conjugated metabolites. In addition, although
procyanidins may survive the acidic conditions of the
stomach (Rios et al. 2002) recent data suggests that
they may be absorbed as lower molecular weight
phenolic acids after microbial degradation (Rios et al.
2003). Thus, further research is needed to fully
characterize ﬂavanols, and their metabolites, for their
platelet-inhibitory effects.
Adding complexity to platelet-ﬂavonoid research is
the fact that several agonists trigger platelet activation,
adhesion and aggregation, all with multiple signaling
pathways that modulate or amplify each of these steps.
Thus, the possibility exists, and research suggests, that
speciﬁc ﬂavonoids and ﬂavonoid-rich foods can affect
platelet function at different steps and via different
mechanisms. In the above studies, DRWexhibited no
platelet inhibitory effect and actually was stimulatory
at a higher ADP (100mmol/l) concentration (Rein
et al. 2000), yet other studies have demonstrated an
inhibitory effect of red wine on platelet function. For
example, studies have shown that red wine consump-
tion can inhibit ex vivo ADP- (Seigneur et al. 1990)
and thrombin-induced (Pace-Asciak et al. 1996)
platelet aggregation in platelet-rich plasma. Similarly,
red wine and grape juice have been found to suppress
cyclic ﬂow reductions in stenosed canine arteries
(Demrow et al. 1995, Osman et al. 1998), as well as,
inhibit ex vivo collagen-induced platelet aggregation
following their consumption by human volunteers
(Keevil et al. 2000, Freedman et al. 2001). This
platelet-inhibitory effect seen with grape juice was not
observed after orange or grapefruit juice consumption
(Osman et al. 1998, Keevil et al. 2000). Like red wine
and cocoa, grape juice contains signiﬁcant amounts of
ﬂavonoids, particularly the ﬂavanols and ﬂavonols,
whereas orange and grapefruit juice, while containing
other classes of polyphenolic compounds, have
minimal amounts of ﬂavanols.
Not all studies have demonstrated platelet-inhibi-
tory effects following the consumption of ﬂavonoid-
rich foods and beverages. Duffy et al. reported
that both acute and chronic consumption of
black tea had no effect on platelet aggregation
(Duffy et al. 2001). The lack of effect of
black tea reported by Duffy et al. may be in part
due to the subject’s daily dose of 325mg ASA,
a large enough dose that may have masked
any subtle, but still important effects of the black
tea. It is important to note that, ADP and thrombin
receptor-activating peptide were used as agonists,
thus, a lack of effect of black tea in this study does
not preclude an effect with other biologically
relevant agonists. In addition, while grapes and
cocoa contain ﬂavanols and procyanidins, tea contains
ﬂavanols, ﬂavanol galloyl esters, theaﬂavins
and thearubigins (Kris-Etherton and Keen 2002).
Thus, future studies are needed to elucidate the effects
of speciﬁc ﬂavanols, and different classes of ﬂavanol
oligomers on platelet function.
Figure 3. Platelet-dependent primary hemostasis in response to the consumption of cocoa, aspirin (ASA; 81mg) or ASA þ cocoa as
measured by a platelet function analyzer (PFA-100e). Blood was drawn before (0h) and 2 and 6h after the consumption of the test
compounds. Whole blood was aspirated through an aperture coated with collagen-epinephrine and the time required to occlude the aperture
measured as the closure time in seconds. Data are presented as mean ^ SD: *Signiﬁcantly different from baseline (0h) within each treatment,
p # 0:0005; (see text for individual p values), (Friedman’s repeated-measures ANOVA on ranks and Tukey’s all-pairwise multiple-comparison
test) (Pearson et al. 2002).
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platelet activity was not addressed in our series of
studies, although several possibilities exist. The well-
known antioxidant activities of numerous ﬂavonoids
(Rice-Evans et al. 1996), including the ﬂavanols found
in cocoa (Sanbongi et al. 1998, Harada et al. 1999,
Zhu et al. 2002), may mediate their platelet effects.
Catechin alone, and synergistically with quercetin, has
been shown to decrease collagen-induced hydrogen
peroxide production, and inhibit collagen-induced
platelet aggregation and adhesion (Pignatelli et al.
2000). As mentioned earlier, catechin has been
observed to inhibit iron-induced platelet hyperactivity
in rats, including a decrease in F2-isoprostanes,
TBARS formation, and vitamin E sparing, all
suggestive of an antioxidant effect of catechin (Blaiche
et al. 2002). Superoxide anion is known to enhance
platelet aggregation, and can react with nitric oxide to
form reactive nitrogen species, thus, decreasing the
antithrombotic activity of nitric oxide (Handin et al.
1977, Ohara et al. 1993). Freedman et al. reported
that purple grape juice consumption increased plasma
protein-independent antioxidant activity, coupled
with a decrease in superoxide production, thus,
suggesting that the mechanism behind reduced
platelet aggregation is through an increase in plate-
let-derived nitric oxide production (Freedman et al.
2001).
Although these studies suggest that ﬂavanols may
exert their platelet effects through an antioxidant
mechanism, they may also act through additional non-
antioxidant mechanisms, such as cell signaling path-
ways and eicosanoid metabolism. For example, purple
grape juice has been reported to attenuate platelet
protein kinase C activity (Freedman et al. 2001), while
catechin and quercetin have been observed to reduce
phospholipase C activity (Pignatelli et al. 2000).
Several studies have reported the ability of individual
ﬂavonoids, or ﬂavonoid-rich foods, to modulate
eicosanoid metabolism, including an increase ratio of
plasma prostacyclin to leukotriene (Schramm et al.
2001, Holt et al. 2002), and reduced thromboxane
production (Corvazier and Maclouf 1985,Chang and
Hsu 1989, Blaiche et al. 2002). In addition, ﬂavanols
and procyanidins from cocoa were shown to inhibit
platelet 12-lipoxygenase (Schewe et al. 2001) and 5-
lipoxygenase (Schewe et al. 2002). Collectively, these
data suggest that ﬂavanols may mediate platelet
function through a multitude of mechanisms.
In summary, research indicates that the ﬂavanols
found in cocoa, as well as other ﬂavanol-rich foods,
favorably modulate platelet function. In light of the
fact that CVD remains as the number one cause of
mortality in the US, coupled with a decline in
ﬂavonoid-rich foods (i.e. fruits and vegetables)
consumption over the past few decades (Patterson
et al. 1990, Block 1991), it becomes increasingly
warranted to study a variety of ﬂavanoid-rich foods for
possible positive vascular effects. In particular,
continued research is needed to characterize the
mechanisms of platelet action of the biologically
present forms of ﬂavanols. Clinical trials are needed
that use a variety of platelet function assays that are
clinically correlated with thromboembolic risk, to fully
determine their role in cardiovascular disease preven-
tion and intervention. With a more complete under-
standing of the physiologic effects of ﬂavanol-rich
foods, future dietary guidelines can be reﬁned and or
modiﬁed to optimize the health beneﬁts of these
compounds.
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